Profile: Iridex Corporation deals with developing, manufacturing, and marketing innovative versatile light-based medical systems & delivery devices. We offer laser based solutions for multiple specialties including aesthetic medicine, ophthalmology, and otolaryngology. Our laser systems are used to treat the three leading causes of irreversible blindness; namely age-related macular degeneration, diabetic retinopathy, and glaucoma. Some of our product names are Venus-i®, Lyra-i®, 810 nm lasers, 577 nm lasers, OcuLight TX and DioVet™. Our Lyra-i® has features such as parallel contact cooling, continuously adjustable spot sizes, & exceptional portability, that gives exceptional hair removal, wrinkle reduction and leg vein removal results. Otologists use our 532 nm laser systems to perform stapedectomy and stapedotomy procedures, to correct certain types of hearing loss.

The company was founded in 1989, has revenues of USD 50-100 Million, has ~20 employees and is ISO 9001, CE certified. NASDAQ:IRIX (SEC Filings)

FDA Registration Number: 2939653